论文部分内容阅读
目的观察依达拉奉联合清开灵治疗急性脑梗死的疗效。方法将84例急性脑梗死患者随机分成治疗组和对照组,每组42例。治疗组采用依达拉奉联合清开灵治疗,对照组单用清开灵治疗,两组常规治疗相同,比较两组治疗前、治疗后14 d神经功能缺损评分及临床疗效。结果治疗组神经功能缺损评分减少程度显著高于对照组(P<0.01);治疗组显效率和总有效率均明显高于对照组(P<0.01)。结论依达拉奉联合清开灵治疗急性脑梗死安全有效,值得临床推广使用。
Objective To observe the curative effect of edaravone combined with qingkailing in treating acute cerebral infarction. Methods Eighty-four patients with acute cerebral infarction were randomly divided into treatment group and control group, 42 cases in each group. The treatment group was treated with edaravone combined with Qingkailing. The control group was treated with Qingkailing alone. The two groups were given the same routine treatment. The neurological deficit score and clinical efficacy of the two groups before and 14 days after treatment were compared. Results The decrease of neurological deficit score in treatment group was significantly higher than that in control group (P <0.01). The effective rate and total effective rate in treatment group were significantly higher than those in control group (P <0.01). Conclusion Edaravone combined with Qing Kai Ling safe and effective treatment of acute cerebral infarction, it is worth promoting the use of clinical.